Navigation Links
China Medical Technologies Reports Third Quarter Financial Results
Date:2/28/2008

13,407

Earnings per ADS

- basic 3.30 2.95 3.73 0.51

- diluted (2) 3.24 2.88 3.52 0.48

Weighted average

number of ADS

- basic 26,765,505 26,210,004 26,238,264 26,238,264

- diluted (2) 29,175,363 30,989,602 31,080,129 31,080,129

Notes:

(1) Revenues, net

- ECLIA 55,428 92,585 96,663 13,251

- FISH -- 30,801 52,831 7,242

- HIFU 106,081 91,510 115,639 15,853

161,509 214,896 265,133 36,346

(2) In computing diluted earnings per ADS for the three months ended

December 31, 2007, interest expense and amortization in connection

with convertible notes were added back to net income before dividing

net income by the diluted number of ADS, which included shares that

may be issued from the conversion of convertible notes. China Medical Technologies, Inc. Reconciliations of Non-GAAP Adjusted Net Income to GAAP Net Income

For the Three Months Ended

December 31, September 30, December 31,

2006 2007 2007

RMB RMB RMB US$

(in thousands except for per ADS information)

GAAP net income 88,428 77,385 97,801 13,407

Adjustments:

Stock compensation

expense 315 5,538 5,074 696

Amortization of

acquired intangible

assets 3,729 22,182 21,876 2,999

Non-GAAP adjusted

net income
'/>"/>

SOURCE China Medical Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine news :

1. Chinas 1-child policy could backfire on its elderly
2. Omnicom Acquires Leading Healthcare Marketing Communications Firm in China
3. Expanding Prevalent Population Will Drive Dramatic Growth for the Asthma Drug Market in China
4. Bridgetech Announces Addition of the Agency for Healthcare Research and Quality as Content Provider in its Development of a Healthcare Web Portal in China
5. China Holdings Appoints Ronald Shon Chairman of Advisory Board to Its Wholly-Owned Subsidiary China Power, Inc.
6. China Bionanometer Industries Corporation Promotes New Cosmetics Product Line in China
7. China Shenghuo Pharmaceutical Holdings, Inc. Begins Full-Scale Launch of 12Ways(R) Chinese Herbal Skin Care Product Line
8. Statement by Mike Leavitt Secretary of Health and Human Services on the United States-China Bilateral Meetings on Food and Drug Safety
9. Supplier Assessments to Help Buyers Identify Reliable China Exporters
10. Study shows lead-based paint problem isnt isolated to China
11. Bracco Announces Initiative to Save Children in China at 2007 Annual Meeting of CGI

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/8/2009)... A jury of 8 people in the Western Distri...,300,000 in pain and suffering for a medical malpr...man and Alicia Nocera of Thomas E. Crenney and Ass...intiff, Vita Monestersky and against the Uniontown...al abdominal hysterectomy at age 18. , ...
(Date:11/8/2009)..., Nov. 8 Pharmaceutical...ior Vice President Ken Johnson released the follow...rm bill: ,, "We are disappointed, but not surpr...llions of hardworking Americans as well as nearly ...atives who voted against the bill. ,, "While we...
(Date:11/8/2009)...ses House Passage of Health Care Reform Bill ,... improve coverage for all Americans ,, BALTIMO...onight the United States House of Representatives ...t would strengthen Medicare for seniors and end di...llions of Americans out of affordable health cover...
(Date:11/7/2009)...ov. 7 The American Medi..., Director of Health at the Family Violence Preven...vice today at its semi-annual policy-making meetin...highest honor the AMA House of Delegates bestows o...wscom.com/cgi-bin/prnh/20081209/AMALOGO ) ,, ...
(Date:11/7/2009)...Faithful Catholics have a responsibility to vigoro...the status quo." ,, WASHINGTON, Nov. 7 /PRN...dent Judie Brown released the following statement ...rt Speaker Nancy Pelosi,s Affordable Health Care f...preserving the status quo for abortion is voted up...
Breaking Medicine News(10 mins):Health News:Pennsylvania Jury Awards $2.3 Million to Fayette County Woman in Medical Malpractice Case 2Health News:PhRMA Statement on House Passage of Health Care Reform Bill 2Health News:PhRMA Statement on House Passage of Health Care Reform Bill 3Health News:AARP Maryland Key Vote News Alert 2Health News:AARP Maryland Key Vote News Alert 3Health News:AMA Honors Family Violence Prevention Expert 2Health News:Statement Regarding Cardinal Rigali's Memo Protecting the 'Status Quo' On Life 2
...est working hours in Europe - a reason that is dri...says a study //. Stress expert Cary Cooper, o... of work seem to be having their negative effect o...udied 2,200 men and found that 37 percent of them ...
... be now treated by a new approach involving releas... made with mice by scientists // at John Hopkins I...-Nathans Institute for Genetic Medicine. The d...called GCN5 is critical for controlling a domino-l...
...BP medication during first trimester of pregnancy ...abies - The Food and Drug Administration reports f...University Medical Center. The study, led by W...rs who took angiotensin converting enzyme inhibito...
...sthan man who has pledged not to marry till he pas...ger for a wife. He has failed in the examination y...ident of Kohari village of Behror town, over 140 k...condary examinations. But he has consistently fail...
...at the COX enzymes interact physically in a bioche...opment of blood vessels. // The study was cond...ania School of Medicine and Queen's University, On...ogy. Collaborators Garret FitzGerald, MD, Directo...
...re made in heaven, they say. But what about homose...omosexuality has been on top //of the flak-charts ...s are only getting stronger against gay and lesbia...is national question requires a national solution,...
Other Medicine News:Health News:Diabetes - New Treatment Approach At John Hopkins 2Health News:Birth Defects Link With ACE Inhibitor Use, FDA Reports 2Health News:New Role of COX Enzymes Discovered 2Health News:Differently Wired and Gay – Are They Children of a Lesser God 2
(Date:11/6/2009)...ire/ -- , - Trial Will Compare NXL103 Wit...f Multi-Resistant Staphylococcus Aureus (MRSA) Inf...tical company focused on the discovery and,develop... significant global,problem of microbial resistanc...ibacterial NXL103 (flopristin/linopristin), has st...
(Date:11/5/2009)... Transcept Pharmaceutica...cal company focused on the development and commerc...portant therapeutic needs in the field of neurosci...eleconference with management to discuss third qua...12, 2009, at 5:00 p.m. Eastern Standard Time. Fin...
(Date:11/5/2009)...ewswire/ -- Renee Cobos, MD, a board certified der...at the University of California, Irvine, announced...us results with Thermage CPT®. The updated sy...ntouring, features a new vibrating hand piece that... comfort. ,, "Thermage has always been popular...
Breaking Medicine Technology:Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 2Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 3Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 4Transcept Pharmaceuticals to Report Third Quarter 2009 Results and Host Conference Call on November 12 2Orange County Dermatologist Garners Outstanding Results With New Thermage CPT(R) 2Good news for some hard to treat hepatitis C patients 49004 1Good news for some hard to treat hepatitis C patients 49004 2MacroGenics and Lilly Achieve Targeted Patient Enrollment in PROTEGE a Global Phase 2 3 Clinical Trial of Teplizumab in Type 1 Diabetes 4596 1MacroGenics and Lilly Achieve Targeted Patient Enrollment in PROTEGE a Global Phase 2 3 Clinical Trial of Teplizumab in Type 1 Diabetes 4596 2MacroGenics and Lilly Achieve Targeted Patient Enrollment in PROTEGE a Global Phase 2 3 Clinical Trial of Teplizumab in Type 1 Diabetes 4596 3MacroGenics and Lilly Achieve Targeted Patient Enrollment in PROTEGE a Global Phase 2 3 Clinical Trial of Teplizumab in Type 1 Diabetes 4596 4A Power Energy Generation Systems Ltd Signs a Biomass Based DG Contract with Sanmenxia New Energy Bio Electricity Co Ltd 12639 1A Power Energy Generation Systems Ltd Signs a Biomass Based DG Contract with Sanmenxia New Energy Bio Electricity Co Ltd 12639 2A Power Energy Generation Systems Ltd Signs a Biomass Based DG Contract with Sanmenxia New Energy Bio Electricity Co Ltd 12639 3
...estive Disease Week data highlight effects of AMIT...C, SAN DIEGO, May 18 New study results indicated...cg lead to significant relief,of overall symptoms ...-C).,These results were presented at Digestive Dis...onal meeting of digestive disease specialists., "...
... that Adding Singulair to Advair Offers no Additio...Control, RESEARCH TRIANGLE PARK, N.C. and TORONTO...oth asthma and allergic rhinitis, or seasonal alle...n when treated with Advair,Diskus(R) (fluticasone ...mpared with Singulair (montelukast sodium). The re...
Other Medicine Technology:New AMITIZA 8 mcg Phase III Studies Demonstrated Overall Symptom Improvement in Adult Women with Irritable Bowel Syndrome with Constipation (IBS-C) 2New AMITIZA 8 mcg Phase III Studies Demonstrated Overall Symptom Improvement in Adult Women with Irritable Bowel Syndrome with Constipation (IBS-C) 3New AMITIZA 8 mcg Phase III Studies Demonstrated Overall Symptom Improvement in Adult Women with Irritable Bowel Syndrome with Constipation (IBS-C) 4New AMITIZA 8 mcg Phase III Studies Demonstrated Overall Symptom Improvement in Adult Women with Irritable Bowel Syndrome with Constipation (IBS-C) 5New AMITIZA 8 mcg Phase III Studies Demonstrated Overall Symptom Improvement in Adult Women with Irritable Bowel Syndrome with Constipation (IBS-C) 6New AMITIZA 8 mcg Phase III Studies Demonstrated Overall Symptom Improvement in Adult Women with Irritable Bowel Syndrome with Constipation (IBS-C) 7Patients With Asthma and Seasonal Allergies Respond Better to Advair(R) for Their Asthma Than Singulair(TM) 2Patients With Asthma and Seasonal Allergies Respond Better to Advair(R) for Their Asthma Than Singulair(TM) 3
...dth of infectious disease ELISA products make us a...ls for faster integration into the busy laboratory...creased reliability and run-to-run consistency. Ou...detection assays for a wide range of serological a...
...dth of infectious disease ELISA products make us a...ls for faster integration into the busy laboratory...creased reliability and run-to-run consistency. Ou...detection assays for a wide range of serological a...
...dth of infectious disease ELISA products make us a...ls for faster integration into the busy laboratory...creased reliability and run-to-run consistency. Ou...detection assays for a wide range of serological a...
...dth of infectious disease ELISA products make us a...ls for faster integration into the busy laboratory...creased reliability and run-to-run consistency. Ou...detection assays for a wide range of serological a...
Medicine Products: